Viral protein determinants of Lassa virus entry and release from polarized epithelial cells.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMC 2838109)

Published in J Virol on January 13, 2010

Authors

Katrin Schlie1, Anna Maisa, Fabian Freiberg, Allison Groseth, Thomas Strecker, Wolfgang Garten

Author Affiliations

1: Institute of Virology, Philipps University Marburg, Hans-Meerwein-Strasse 2, 35043 Marburg, Germany.

Articles citing this

Anterograde or retrograde transsynaptic labeling of CNS neurons with vesicular stomatitis virus vectors. Proc Natl Acad Sci U S A (2011) 1.40

Identification of two functional domains within the arenavirus nucleoprotein. J Virol (2010) 1.10

A role for the C terminus of Mopeia virus nucleoprotein in its incorporation into Z protein-induced virus-like particles. J Virol (2010) 1.10

Envelope glycoprotein of arenaviruses. Viruses (2012) 1.06

Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever. Virol J (2010) 0.92

Multifunctional nature of the arenavirus RING finger protein Z. Viruses (2012) 0.92

Acidic pH-Induced Conformations and LAMP1 Binding of the Lassa Virus Glycoprotein Spike. PLoS Pathog (2016) 0.90

Advanced vaccine candidates for Lassa fever. Viruses (2012) 0.90

Nipah virus entry and egress from polarized epithelial cells. J Virol (2013) 0.89

Shedding of soluble glycoprotein 1 detected during acute Lassa virus infection in human subjects. Virol J (2010) 0.83

Mumps Virus Is Released from the Apical Surface of Polarized Epithelial Cells, and the Release Is Facilitated by a Rab11-Mediated Transport System. J Virol (2015) 0.82

Molecular determinants of arenavirus Z protein homo-oligomerization and L polymerase binding. J Virol (2011) 0.81

Tamiflu-resistant but HA-mediated cell-to-cell transmission through apical membranes of cell-associated influenza viruses. PLoS One (2011) 0.79

The bi-functional organization of human basement membranes. PLoS One (2013) 0.78

Polar release of pathogenic Old World hantaviruses from renal tubular epithelial cells. Virol J (2012) 0.77

Uncovering viral protein-protein interactions and their role in arenavirus life cycle. Viruses (2012) 0.77

Preferential Budding of Vesicular Stomatitis Virus from the Basolateral Surface of Polarized Epithelial Cells Is Not Solely Directed by Matrix Protein or Glycoprotein. J Virol (2015) 0.77

Targeting of arenavirus RNA synthesis by a carboxamide-derivatized aromatic disulfide with virucidal activity. PLoS One (2013) 0.75

Renal biopsy: use of biomarkers as a tool for the diagnosis of focal segmental glomerulosclerosis. Dis Markers (2014) 0.75

Articles cited by this

Asymmetric budding of viruses in epithelial monlayers: a model system for study of epithelial polarity. Proc Natl Acad Sci U S A (1978) 6.85

A prospective study of the epidemiology and ecology of Lassa fever. J Infect Dis (1987) 5.27

Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from southern Africa. PLoS Pathog (2009) 4.88

Excretion of hepatitis B surface antigen particles from mouse cells transformed with cloned viral DNA. Proc Natl Acad Sci U S A (1980) 3.97

New low-viscosity overlay medium for viral plaque assays. Virol J (2006) 3.92

Lassa virus isolation from Mastomys natalensis rodents during an epidemic in Sierra Leone. Science (1974) 3.86

Glycoprotein cytoplasmic domain sequences required for rescue of a vesicular stomatitis virus glycoprotein mutant. J Virol (1989) 3.81

Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP. J Virol (2002) 3.62

A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis (1987) 3.51

The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P. Proc Natl Acad Sci U S A (2001) 3.43

The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies. Proc Natl Acad Sci U S A (2003) 3.34

Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. BMJ (1995) 3.21

Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature (2007) 3.06

Contribution of ebola virus glycoprotein, nucleoprotein, and VP24 to budding of VP40 virus-like particles. J Virol (2004) 2.92

Lassa virus Z protein is a matrix protein and sufficient for the release of virus-like particles [corrected]. J Virol (2003) 2.87

Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles. J Virol (2007) 2.82

Transferrin receptor polarity and recycling accuracy in "tight" and "leaky" strains of Madin-Darby canine kidney cells. J Cell Biol (1986) 2.52

New opportunities for field research on the pathogenesis and treatment of Lassa fever. Antiviral Res (2007) 2.47

A role for dystroglycan in basement membrane assembly. Cell (1998) 2.36

Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages. J Virol (1996) 2.26

Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia. PLoS Pathog (2008) 2.23

Pathologic and virologic study of fatal Lassa fever in man. Am J Pathol (1982) 2.14

The membrane-proximal intracytoplasmic tyrosine residue of HIV-1 envelope glycoprotein is critical for basolateral targeting of viral budding in MDCK cells. EMBO J (1997) 2.10

Polarity of influenza and vesicular stomatitis virus maturation in MDCK cells: lack of a requirement for glycosylation of viral glycoproteins. Proc Natl Acad Sci U S A (1979) 2.09

Novel infectious particles generated by expression of the vesicular stomatitis virus glycoprotein from a self-replicating RNA. Cell (1994) 2.08

Identification of the lymphocytic choriomeningitis virus (LCMV) proteins required to rescue LCMV RNA analogs into LCMV-like particles. J Virol (2002) 1.97

Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells. J Immunol (2004) 1.96

Interactions between viruses and lymphocytes. I. In vivo replication of lymphocytic choriomeningitis virus in mononuclear cells during both chronic and acute viral infections. J Immunol (1978) 1.95

Mastomys natalensis and Lassa fever, West Africa. Emerg Infect Dis (2006) 1.94

Human parainfluenza virus type 1 matrix and nucleoprotein genes transiently expressed in mammalian cells induce the release of virus-like particles containing nucleocapsid-like structures. J Virol (1999) 1.93

Identification of a novel consensus sequence at the cleavage site of the Lassa virus glycoprotein. J Virol (2000) 1.79

Distribution of dystroglycan in normal adult mouse tissues. J Histochem Cytochem (1998) 1.77

IL8 release, tight junction and cytoskeleton dynamic reorganization conducive to permeability increase are induced by dengue virus infection of microvascular endothelial monolayers. J Gen Virol (2004) 1.77

Hunting of peridomestic rodents and consumption of their meat as possible risk factors for rodent-to-human transmission of Lassa virus in the Republic of Guinea. Am J Trop Med Hyg (1996) 1.70

Lassa and Mopeia virus replication in human monocytes/macrophages and in endothelial cells: different effects on IL-8 and TNF-alpha gene expression. J Med Virol (1999) 1.65

Signal peptide of Lassa virus glycoprotein GP-C exhibits an unusual length. FEBS Lett (2003) 1.62

Detection of Lassa virus RNA in specimens from patients with Lassa fever by using the polymerase chain reaction. J Clin Microbiol (1990) 1.61

Expression of the human immunodeficiency virus envelope glycoprotein is restricted to basolateral surfaces of polarized epithelial cells. J Virol (1989) 1.59

Role of matrix and fusion proteins in budding of Sendai virus. J Virol (2001) 1.58

Characterization of the Lassa virus matrix protein Z: electron microscopic study of virus-like particles and interaction with the nucleoprotein (NP). Virus Res (2004) 1.54

Phylogeny of the genus Arenavirus. Curr Opin Microbiol (2008) 1.49

Effect of environmental factors on aerosol-induced Lassa virus infection. J Med Virol (1984) 1.47

Basal lamina strengthens cell membrane integrity via the laminin G domain-binding motif of alpha-dystroglycan. Proc Natl Acad Sci U S A (2009) 1.47

Virus infection of polarized epithelial cells. Adv Virus Res (1993) 1.44

Requirements for the assembly and release of Newcastle disease virus-like particles. J Virol (2006) 1.40

Apical entry and release of severe acute respiratory syndrome-associated coronavirus in polarized Calu-3 lung epithelial cells. J Virol (2005) 1.36

Measles virus matrix protein specifies apical virus release and glycoprotein sorting in epithelial cells. EMBO J (2000) 1.33

Dendritic cells in the kidney. J Am Soc Nephrol (2007) 1.29

Arenavirus Z-glycoprotein association requires Z myristoylation but not functional RING or late domains. J Virol (2007) 1.27

Genetic identification of Kodoko virus, a novel arenavirus of the African pigmy mouse (Mus Nannomys minutoides) in West Africa. Virology (2007) 1.22

Mumps virus matrix, fusion, and nucleocapsid proteins cooperate for efficient production of virus-like particles. J Virol (2009) 1.17

Phylogeny and evolution of old world arenaviruses. Virology (2006) 1.15

Fluctuation of abundance and Lassa virus prevalence in Mastomys natalensis in Guinea, West Africa. Vector Borne Zoonotic Dis (2007) 1.14

Experimental Lassa virus infection in the squirrel monkey. Am J Pathol (1975) 1.13

The RING domain and the L79 residue of Z protein are involved in both the rescue of nucleocapsids and the incorporation of glycoproteins into infectious chimeric arenavirus-like particles. J Virol (2009) 1.13

Two distinct oncornaviruses harbor an intracytoplasmic tyrosine-based basolateral targeting signal in their viral envelope glycoprotein. J Virol (1997) 1.12

Replication of dengue and junin viruses in cultured rabbit and human endothelial cells. Infect Immun (1978) 1.12

Polarized entry of canine parvovirus in an epithelial cell line. J Virol (1989) 1.08

Pneumotropic revertants derived from a pantropic mutant, F1-R, of Sendai virus. Virology (1991) 1.07

Hantavirus causing hemorrhagic fever with renal syndrome enters from the apical surface and requires decay-accelerating factor (DAF/CD55). J Virol (2008) 1.05

Reovirus preferentially infects the basolateral surface and is released from the apical surface of polarized human respiratory epithelial cells. J Infect Dis (2008) 1.02

Opposite polarity of virus budding and of viral envelope glycoprotein distribution in epithelial cells derived from different tissues. J Cell Biol (1992) 1.00

Apical budding of a recombinant influenza A virus expressing a hemagglutinin protein with a basolateral localization signal. J Virol (2002) 0.99

Basolateral budding of Marburg virus: VP40 retargets viral glycoprotein GP to the basolateral surface. J Infect Dis (2007) 0.98

Human cytomegalovirus infects Caco-2 intestinal epithelial cells basolaterally regardless of the differentiation state. J Virol (2000) 0.96

Foamy virus envelope glycoprotein is sufficient for particle budding and release. J Virol (2003) 0.93

Basolateral sorting of the HIV type 2 and SIV envelope glycoproteins in polarized epithelial cells: role of the cytoplasmic domain. AIDS Res Hum Retroviruses (1997) 0.92

Human respiratory syncytial virus glycoproteins are not required for apical targeting and release from polarized epithelial cells. J Virol (2008) 0.91

Basolateral entry and release of New and Old World arenaviruses from human airway epithelia. J Virol (2008) 0.90

A murine and a porcine coronavirus are released from opposite surfaces of the same epithelial cells. Virology (1996) 0.88

Vesicular stomatitis virus glycoprotein does not determine the site of virus release in polarized epithelial cells. J Virol (2002) 0.88

Polarized entry and release of Junin virus, a New World arenavirus. J Gen Virol (2005) 0.84

Assembly of arenavirus envelope glycoprotein GPC in detergent-soluble membrane microdomains. J Virol (2009) 0.83

[Characteristics of monoclonal antibodies against Lassa virus]. Mol Gen Mikrobiol Virusol (1987) 0.77

Articles by these authors

New low-viscosity overlay medium for viral plaque assays. Virol J (2006) 3.92

Lassa virus Z protein is a matrix protein and sufficient for the release of virus-like particles [corrected]. J Virol (2003) 2.87

Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium. J Virol (2006) 2.80

Endoproteolytic processing of the lymphocytic choriomeningitis virus glycoprotein by the subtilase SKI-1/S1P. J Virol (2003) 2.57

Crystal structure of the borna disease virus nucleoprotein. Structure (2003) 2.30

Ebola virus: unravelling pathogenesis to combat a deadly disease. Trends Mol Med (2006) 1.92

Identification of Lassa virus glycoprotein signal peptide as a trans-acting maturation factor. EMBO Rep (2003) 1.85

Ectodomain shedding of the glycoprotein GP of Ebola virus. EMBO J (2004) 1.73

Aging is associated with chronic innate immune activation and dysregulation of monocyte phenotype and function. Aging Cell (2012) 1.71

Effects of donor pre-treatment with dopamine on survival after heart transplantation: a cohort study of heart transplant recipients nested in a randomized controlled multicenter trial. J Am Coll Cardiol (2011) 1.63

Signal peptide of Lassa virus glycoprotein GP-C exhibits an unusual length. FEBS Lett (2003) 1.62

Infection of naive target cells with virus-like particles: implications for the function of ebola virus VP24. J Virol (2006) 1.61

HIV infection induces age-related changes to monocytes and innate immune activation in young men that persist despite combination antiretroviral therapy. AIDS (2012) 1.55

Characterization of the Lassa virus matrix protein Z: electron microscopic study of virus-like particles and interaction with the nucleoprotein (NP). Virus Res (2004) 1.54

Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacy. J Infect Dis (2011) 1.47

Synthetic generation of influenza vaccine viruses for rapid response to pandemics. Sci Transl Med (2013) 1.47

Avian-virus-like receptor specificity of the hemagglutinin impedes influenza virus replication in cultures of human airway epithelium. Virology (2007) 1.44

In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent protein. J Infect Dis (2007) 1.43

Evidence for a decrease in transmission of Ebola virus--Lofa County, Liberia, June 8-November 1, 2014. MMWR Morb Mortal Wkly Rep (2014) 1.42

Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors. J Virol (2010) 1.40

Current ebola vaccines. Expert Opin Biol Ther (2012) 1.30

Inclusion bodies are a site of ebolavirus replication. J Virol (2012) 1.29

The role of myristoylation in the membrane association of the Lassa virus matrix protein Z. Virol J (2006) 1.27

Minigenomes, transcription and replication competent virus-like particles and beyond: reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever viruses. Antiviral Res (2011) 1.24

Efficient budding of the tacaribe virus matrix protein z requires the nucleoprotein. J Virol (2010) 1.20

Nanopore Sequencing as a Rapidly Deployable Ebola Outbreak Tool. Emerg Infect Dis (2016) 1.20

Novel type II transmembrane serine proteases, MSPL and TMPRSS13, Proteolytically activate membrane fusion activity of the hemagglutinin of highly pathogenic avian influenza viruses and induce their multicycle replication. J Virol (2010) 1.20

Inhibition of influenza virus infection in human airway cell cultures by an antisense peptide-conjugated morpholino oligomer targeting the hemagglutinin-activating protease TMPRSS2. J Virol (2010) 1.15

Primary and metastatic cardiac sarcomas: a 12-year experience at a German heart center. Int J Clin Exp Pathol (2012) 1.13

MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition. Vaccine (2009) 1.13

An upstream open reading frame modulates ebola virus polymerase translation and virus replication. PLoS Pathog (2013) 1.12

Profile and persistence of the virus-specific neutralizing humoral immune response in human survivors of Sudan ebolavirus (Gulu). J Infect Dis (2013) 1.12

Rescue of Ebola virus from cDNA using heterologous support proteins. Virus Res (2004) 1.12

Taxonomic reorganization of the family Bornaviridae. Arch Virol (2014) 1.09

Old and New World arenaviruses share a highly conserved epitope in the fusion domain of the glycoprotein 2, which is recognized by Lassa virus-specific human CD4+ T-cell clones. Virology (2004) 1.09

The Merits of Malaria Diagnostics during an Ebola Virus Disease Outbreak. Emerg Infect Dis (2016) 1.08

Lassa virus glycoprotein signal peptide displays a novel topology with an extended endoplasmic reticulum luminal region. J Biol Chem (2004) 1.06

Role of the transmembrane domain of marburg virus surface protein GP in assembly of the viral envelope. J Virol (2007) 1.06

Clinical aspects of Marburg hemorrhagic fever. Future Virol (2011) 1.06

Potent inhibitors of furin and furin-like proprotein convertases containing decarboxylated P1 arginine mimetics. J Med Chem (2010) 1.05

A novel Ebola virus expressing luciferase allows for rapid and quantitative testing of antivirals. Antiviral Res (2013) 1.04

Matriptase, HAT, and TMPRSS2 activate the hemagglutinin of H9N2 influenza A viruses. J Virol (2012) 1.03

Molecular mechanisms of interspecies transmission and pathogenicity of influenza viruses: Lessons from the 2009 pandemic. Bioessays (2011) 1.00

TMPRSS2 is a host factor that is essential for pneumotropism and pathogenicity of H7N9 influenza A virus in mice. J Virol (2014) 0.99

Left atrial myxoma with papillary fibroelastoma-like features. Int J Clin Exp Pathol (2011) 0.99

Vacuolar protein sorting pathway contributes to the release of Marburg virus. J Virol (2008) 0.99

Highly potent inhibitors of proprotein convertase furin as potential drugs for treatment of infectious diseases. J Biol Chem (2012) 0.98

The role of single N-glycans in proteolytic processing and cell surface transport of the Lassa virus glycoprotein GP-C. Virol J (2006) 0.96

Activation of influenza viruses by proteases from host cells and bacteria in the human airway epithelium. Pathog Dis (2013) 0.94

Sangassou virus, the first hantavirus isolate from Africa, displays genetic and functional properties distinct from those of other murinae-associated hantaviruses. J Virol (2012) 0.93

Multifunctional nature of the arenavirus RING finger protein Z. Viruses (2012) 0.92

Increased glucose metabolic activity is associated with CD4+ T-cell activation and depletion during chronic HIV infection. AIDS (2014) 0.92

Crystal structure of the Borna disease virus matrix protein (BDV-M) reveals ssRNA binding properties. Proc Natl Acad Sci U S A (2009) 0.91

Inhibition of Lassa virus glycoprotein cleavage and multicycle replication by site 1 protease-adapted alpha(1)-antitrypsin variants. PLoS Negl Trop Dis (2009) 0.91

Papillary fibroelastoma of the mitral valve: appearance in 64-slice spiral computed tomography, magnetic resonance imaging, and echocardiography. Eur Heart J (2007) 0.90

Profiling the native specific human humoral immune response to Sudan Ebola virus strain Gulu by chemiluminescence enzyme-linked immunosorbent assay. Clin Vaccine Immunol (2012) 0.90

Fulminant endocarditis caused by Streptobacillus moniliformis in a young man. J Thorac Cardiovasc Surg (2007) 0.90

The role of reverse genetics systems in studying viral hemorrhagic fevers. Thromb Haemost (2005) 0.89

Maturation cleavage within the ectodomain of Lassa virus glycoprotein relies on stabilization by the cytoplasmic tail. FEBS Lett (2010) 0.87

Effect of Artesunate-Amodiaquine on Mortality Related to Ebola Virus Disease. N Engl J Med (2016) 0.86

Cleavage of the Junin virus nucleoprotein serves a decoy function to inhibit the induction of apoptosis during infection. J Virol (2012) 0.85

Endothelial cell activation promotes foam cell formation by monocytes following transendothelial migration in an in vitro model. Exp Mol Pathol (2012) 0.85

Identification of the first synthetic inhibitors of the type II transmembrane serine protease TMPRSS2 suitable for inhibition of influenza virus activation. Biochem J (2013) 0.84

RNA induced polymerization of the Borna disease virus nucleoprotein. Virology (2009) 0.84

Oligomerization and assembly of the matrix protein of Borna disease virus. FEBS Lett (2005) 0.84

The hemagglutinin: a determinant of pathogenicity. Curr Top Microbiol Immunol (2014) 0.83

Hemagglutinin activating host cell proteases provide promising drug targets for the treatment of influenza A and B virus infections. Vaccine (2012) 0.83

Arenavirus budding: a common pathway with mechanistic differences. Viruses (2013) 0.83

Characterization of Lassa virus glycoprotein oligomerization and influence of cholesterol on virus replication. J Virol (2009) 0.82

Viremic and Virologically Suppressed HIV Infection Increases Age-Related Changes to Monocyte Activation Equivalent to 12 and 4 Years of Aging, Respectively. J Acquir Immune Defic Syndr (2015) 0.82

Activation of influenza A viruses by host proteases from swine airway epithelium. J Virol (2013) 0.81

The role of oligomerization for the biological functions of the arenavirus nucleoprotein. Arch Virol (2013) 0.81

Inflammatory thoracic aortic aneurysm (lymphoplasmacytic thoracic aortitis): a 13-year-experience at a German Heart Center with emphasis on possible role of IgG4. Int J Clin Exp Pathol (2013) 0.81

Identification of the amino terminal subunit of the glycoprotein of Borna disease virus. FEBS Lett (2002) 0.81

Maturation of Borna disease virus glycoprotein. FEBS Lett (2005) 0.79

Early failure of a mechanical bileaflet aortic valve prosthesis due to pannus: a rare complication. J Thorac Cardiovasc Surg (2008) 0.79

Isolation of influenza viruses in MDCK 33016PF cells and clearance of contaminating respiratory viruses. Vaccine (2011) 0.78

Crystallization and preliminary X-ray analysis of the matrix protein of Borna disease virus. Acta Crystallogr D Biol Crystallogr (2002) 0.77

Development of substrate analogue inhibitors for the human airway trypsin-like protease HAT. Bioorg Med Chem Lett (2011) 0.77

Gangliosides are not essential for influenza virus infection. Glycoconj J (2006) 0.77

Spatiotemporal analysis of Guaroa virus diversity, evolution, and spread in South America. Emerg Infect Dis (2015) 0.76

Genetic polymorphisms in the CD14 gene are associated with monocyte activation and carotid intima-media thickness in HIV-infected patients on antiretroviral therapy. Medicine (Baltimore) (2016) 0.75

Giant left ventricular aneurysm 20 years after mitral valve replacement: a very rare complication. J Heart Valve Dis (2010) 0.75

Minimally invasive vein harvesting with the SaphLITE retractor system: is it really better? Heart Surg Forum (2006) 0.75

The microtubule motor protein KIF13A is involved in intracellular trafficking of the Lassa virus matrix protein Z. Cell Microbiol (2013) 0.75

Stenting of the superior vena cava in a patient with a total artificial heart. J Thorac Cardiovasc Surg (2008) 0.75

Maguari Virus Associated with Human Disease. Emerg Infect Dis (2017) 0.75